Filing Details

Accession Number:
0001123292-17-000299
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-31 18:43:43
Reporting Period:
2017-01-27
Filing Date:
2017-01-31
Accepted Time:
2017-01-31 18:43:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881524 Vivus Inc VVUS Pharmaceutical Preparations (2834) 943136179
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640688 T Santosh Varghese C/O Vivus, Inc.
900 E. Hamilton Ave., Suite 550
Campbell CA 95008
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-01-28 429 $1.11 74,037 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2017-01-27 385,000 $0.00 385,000 $1.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
385,000 2024-01-27 No 4 A Direct
Footnotes
  1. Sold to pay the tax liability resulting from the vesting of 925 restricted stock units granted on January 28, 2014.
  2. Twenty-five percent (25%) of the total number of shares underlying the option will vest and become exercisable on January 27, 2018, and one forty-eighth (1/48th) of the total number of shares underlying the option will vest on the 27th of each month thereafter, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2010 Equity Incentive Plan) on the relevant vesting dates.